Stryker-Aktie mit Kursgewinnen (349,8117 €)

https://www.finanznachrichten.de/nachrichten-2025-05/65281043-stryker-corp-q1-profit-decreases-but-beats-estimates-020.htm WASHINGTON (dpa-AFX) - Stryker Corp. (SYK) revealed earnings for first quarter that decreased from the same period last year but beat the Street estimates. The company's earnings came in at $654 million, or $1.69 per share. This compares with $788 million, or $2.05 per share, last year. Excluding items, Stryker Corp. reported adjusted earnings of $1097 million or $2.84 per share for the period. Analysts on average had expected the company to earn $2.73 per share. Analysts' estimates typically exclude special items. The company's revenue for the period rose 11.9% to $5.867 billion from $5.243 billion last year. Stryker Corp. earnings at a glance (GAAP) : -Earnings: $654 Mln. vs. $788 Mln. last year. -EPS: $1.69 vs. $2.05 last year. -Revenue: $5.867 Bln vs. $5.243 Bln last year. -Guidance: Full year EPS guidance: $13.20 to $13.45 Copyright(c) 2025 RTTNews.com. All Rights Reserved Copyright RTT News/dpa-AFX © 2025 AFX News

So tragisch wie die Überschrift sehe ich das jetzt nicht. Wenn ich das richtig verstanden habe ,hat der CEO verbilligte Aktien als Zuteilung erhalten und die gleich wieder verkauft . Ich verweise auf den Hyperlink Stryker Co. (NYSE:SYK - Get Free Report) CEO Kevin Lobo sold 57,313 shares of Stryker stock in a transaction on Thursday, November 7th. The stock was sold at an average price of $368.70, for a total transaction of $21,131,303.10. Following the completion of the transaction, the chief executive officer now owns 100,027 shares in the company, valued at approximately $36,879,954.90. The trade was a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Get Stryker alerts: Stryker Stock Up 1.7 % https://www.marketbeat.com/instant-alerts/stryker-co-nysesyk-ceo-sells-2113130310-in-stock-2024-11-08/ Shares of SYK traded up $6.13 during trading hours on Friday, hitting $375.96. The company had a trading volume of 1,009,226 shares, compared to its average volume of 1,254,526. The stock has a market capitalization of $143.32 billion, a price-to-earnings ratio of 40.30, a P/E/G ratio of 2.78 and a beta of 0.91. The firm has a fifty day moving average price of $361.46 and a 200-day moving average price of $345.63. Stryker Co. has a 52-week low of $266.93 and a 52-week high of $377.83. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.22 and a current ratio of 1.91. Stryker (NYSE:SYK - Get Free Report) last released its quarterly earnings data on Tuesday, October 29th. The medical technology company reported $2.87 earnings per share for the quarter, beating analysts' consensus estimates of $2.77 by $0.10. The business had revenue of $5.49 billion during the quarter, compared to analyst estimates of $5.37 billion. Stryker had a net margin of 16.34% and a return on equity of 23.07%. Stryker's revenue was up 11.9% compared to the same quarter last year. During the same period last year, the business earned $2.46 EPS. On average, equities research analysts forecast that Stryker Co. will post 12.06 EPS for the current fiscal year. Ad WealthPress Download for free: Tesla investment guide This doesn’t happen often… But our resident Tesla trading expert has just published a brand new e-book outlining his bullish case for Tesla. And he’s currently giving away digital copies for free. claim your free digital copy today, simply follow this link and enter your email address. Analysts Set New Price Targets SYK has been the subject of several recent analyst reports. Morgan Stanley upped their price objective on shares of Stryker from $345.00 to $350.00 and gave the company an "equal weight" rating in a research note on Monday, July 15th. Barclays upped their price target on Stryker from $402.00 to $418.00 and gave the company an "overweight" rating in a research report on Thursday, October 31st. Truist Financial lifted their price objective on Stryker from $370.00 to $380.00 and gave the stock a "hold" rating in a research report on Wednesday, October 30th. BTIG Research upped their price objective on shares of Stryker from $383.00 to $394.00 and gave the stock a "buy" rating in a report on Wednesday, October 30th. Finally, Needham & Company LLC raised their target price on shares of Stryker from $393.00 to $409.00 and gave the stock a "buy" rating in a research report on Wednesday, October 30th. Five analysts have rated the stock with a hold rating and sixteen have issued a buy rating to the stock. According to data from MarketBeat.com, Stryker has an average rating of "Moderate Buy" and an average price target of $393.65.